You are here: Industry Insights > sales

News List

GSK updates its sales rep incentives pharmatimes
May 28, 2019
Specifically in Specialty Care, the capped variable pay element of a sales representative’s compensation will be evaluated on the basis of individual sales targets.
Sales of Osimertinib Approaching RMB 2 Billion in China in 2018 PharmaSources/Caicai
April 03, 2019
Global sales of osimertinib reached USD 1.86 billion in 2018, growing by 95%; it has become the best-selling tumor drug of AstraZeneca...
Bayer animal health sale can rake in $8B and bids from private equity fiercepharma
March 21, 2019
AbbVie and Roche are looking to move key oncology drug Venclexta deeper into the blood cancer arena, but their ambitions in multiple myeloma just took a hit.
Top 20 Companies by Global Prescription Drug Sales in 2024 Weiyi
December 14, 2018
According to the forecast of EvaluatePharma, the pharmaceutical market is going out of the sluggish state following the financial crisis and accelerating growth, to an compound annual growth rate (CAGR) of 6% between now and 2024.
Sales of Roche’s Rituxan Have Started to Decline as Biosimilars Thereof are Marketed 1℃
November 02, 2018
Celltrion and Teva Pharmaceutical released big news on October 11, 2018 that the Rituxan® (rituximab) biosimilar. After the marketing, CT-P10 will become the first Rituxan® (rituximab) biosimilar approved for marketing in the U.S.
In kickbacks case, CA insurance chief says AbbVie used nurse 'ambassadors' to protect Humira sales fiercepharma
September 20, 2018
AbbVie has had success growing Humira sales to the top position in biopharma globally, but a new lawsuit in California alleges the company used a massive fraud scheme to protect revenues at the expense of patient safety.
CDC: E-Cigarette Sales in the United States Climb As Prices Fall drugs
August 06, 2018
There was a large increase in sales of electronic cigarettes (e-cigarettes) and related products in the United States in recent years as their prices fell, according to a study published online Aug. 2 in the U.S. Centers for Disease Control and Prevention
Allergan preludes major selloffs with $650M Almirall dermatology sale fiercepharma
August 06, 2018
Allergan, which is shopping assets to help turn its stock price around, has taken its first small step into selloff land.
Boehringer sales rise as Jardiance and Ofev thrive pharmatimes
August 02, 2018
Boehringer Ingelheim saw its first-half prescription drug sales rise on the back of strong performances for Jardiance and Ofev.
Pfizer's rejig made for growth, but it's also handy for a future split fiercepharma
August 01, 2018
Pfizer’s new three-unit structure may be all about driving growth for now, but don’t count out a long-awaited generics divestment down the line.

Previous page 1 2 3 4 Next page